Immunity and Its Effect on the Incidence of Multiple Organ Failure in Patients after the Heart Surgery

The purpose of the study is to identify the components of immunity, which might predict the development of multiple organ failure in patients after heart surgery.

Material and methods. The study included 40 patients who were operated in cardiac surgery Department. The inclusion criteria were the presence of indications for cardiac surgery. The exclusion criteria were the presence of infective endocarditis in patients. Before the operation and after 24 hours we studied the blood level of leukocytes and lymphocytes. We analyzed the phenotype of immune cells using monoclonal antibodies, serum levels of procalcitonin and C3 and C4 complement components. All patients were evaluated for multiple organ disfunction (MOD) using the SOFA scale.

The results showed that cardiac surgery leads to the development of MOD, statistically significant multidirectional changes in both quantitative and qualitative composition of all cells of the immune system, significant changes in the level of C3 and C4 components of the cascade of complement and plasma level of pro-calcitonin. ROC analysis was revealed that the relative content of monocytes is less than 7.1% of the number of leukocytes as well as the absolute content of monocytes with the CD14 + HLA-DR + phenotype less than 0.32_109/l in the preoperative period, and the C3 level of the complement component less than 0.52 g/l, as well as the maximum SOFA score in the postoperative period, were the best predictors of MOD after the procedures.

Conclusion. The components of innate immunity make it possible to predict the complication of the cardiac surgery, earlier than the SOFA scale.

1. Ponasenko A.V., Sinitsky M.Y., Khutornaya M.V., Barabash O.L. Genetic Markers of Systemic Inflammatory Response in Cardiac Surgery (Review). Obshchaya reanimatologiya=General Reanimatology. 2017; 13 (6): 48–59. [In Russ., In Engl.] DOI: 10.15360/1813-9779-2017-6-48-59

2. Mizock B.A. The Multiple Organ Dysfunction Syndrom. Disease-amonth. 55 (8): 476-526 September 2009. DOI: 10.1016/j.disamonth.2009.04.002.

3. Federyakin D.V., Goncharuk A.V., Anokhin A.V., Dj’Arah Munzer D.O. Dynamics of Cognitive Functions and Proinflammatory Cytokines in Different Variants of Coronary Artery Bypass Surgery. Obshchaya reanimatologiya= General Reanimatology. 2018; 14 (6): 4–11. [In Russ., In Engl.] DOI: 10.15360/1813-9779-2018-6-4-11.

4. Bone R.C. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996 Oct 15; 125: 680–687.

5. Munford R. S., Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001 Feb; 163 (2): 316–321. DOI: 10.1164/ajrccm.163.2.2007102.

6. Venet F., Lepape A., Monneret G. Clinical review: flow cytometry perspectives in the ICU – from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit. Care. 2011; 15 (5): 231. DOI: 10.1186/cc10333.

7. Monneret G., Venet F., Pachot A., Lepape A. Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol. Med. 2008. Jan-Feb; 14 (1–2): 64–78. DOI: 10.2119/2007-00102.Monneret.

8. Hoesel L.M., Neff T.A., Neff S.B., Younger J.G., Olle E.W., Gao H., Pianko M.J., Bernacki K.D., Sarma J.V., Ward P.A. Harmful and protective roles of neutrophils in sepsis. Shock. 2005 Jul; 24 (1): 40–47.

9. Adib-Conquy M., Cavaillon J.M. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009 Jan; 101 (1): 36-47.

10. Monneret G., Lepape A., Voirin N., Bohe J., Venet F., Debard A.L., Thizy H., Bienvenu J., Gueyffier F., Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006 Aug; 32 (8): 1175–1183. DOI: 10.1007/s00134-006-0204-8.

11. Nierhaus A., Montag B., Timmler N., Frings D.P., Gutensohn K., Jung R., Schneider C.G., Pothmann W., Brassel A.K., Schulte A., Esch J. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 2003 Apr; 29 (4): 646–651. DOI: 10.1007/s00134-003-1666-6.

12. Danikas D.D., Karakantza M., Theodorou G.L., Sakellaropoulos G.C., Gogos C.A. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol. 2008 Oct; 154 (1): 87–97. DOI: 10.1111/j.13652249.2008.03737.x.

13. Franke A., Lante W., Zoeller L.G., Kurig E., Weinhold C., Markewitz A. Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon? Interact Cardiovasc Thorac Surg. 2008 Apr; 7 (2): 207–211. DOI: 10.1510/icvts.2007.158899.

14. Kim O. Y., Monsel A., Bertrand M., Coriat P., Cavaillon J. M., Adib-Conquy M. Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care. 2010; 14 (2): R61. DOI: 10.1186/cc8959.

15. Golovkin A.S., Matveeva V.G., Kudryavcev I.V., Grigorev E.V., Velikanova E.A., Bajrakova Yu.V. Subpopulations of blood monocytes with uncomplicated during the perioperative period of coronary artery bypass grafting. Medicinskaya immunologiya. 2012; 14 (4–5): 305–312. [In Russ.] DOI: 10.15789/1563-0625-2012-4-5-305-312.

16. Ceriani R., Mazzoni M., Bortone F., Gandini S., Solinas C., Susini G, Parodi O. Application of the Sequential Organ Failure Assessment Score to Cardiac Surgical Patients. Chest. 2003 Apr; 123 (4): 1229–1239.

17. Doerr F., Badreldin A. M., Heldwein M.B., Bossert T., Richter M., Lehmann T., Bayer O., Hekmat K. A comparative study of four intensive care outcome prediction models in cardiac surgery patients. J Cardiothorac Surg. 2011 Mar 1; 6: 21. DOI: 10.1186/1749-8090-6-21.

18. Wan S., LeClerc J.L., Vincent J.L. Inflammatory response to cardiopulmonary bypass. Mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 679–692.

19. Paparella D., Yau T.M., Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002 Feb; 21 (2): 232–244.

20. Laffey J. G., Boylan J. F., Cheng D. C. The systemic inflammatory response to cardiac surgery. Implications for the anesthesiologist. Anesthesiology 2002; 97: 215–252.

21. Ponasenko A.V., Sinitsky M.Y., Khutornaya M.V., Barabash O.L. Genetic Markers of Systemic Inflammatory Response in Cardiac Surgery (Review). Obshchaya reanimatologiya=General Reanimatology. 2017; 13 (6): 48–59. [In Russ., In Engl.]. DOI: 10.15360/1813-9779-2017-6-48-59.

22. Pfortmueller C. A., Meisel C., Fux M., Schefold J. C. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers. Intensive Care Med Exp. 2017 Dec; 5: 49. DOI: 10.1186/s40635-017-0163-0.

23. Rittirsch D., Redland H., Huber-Lang M. Role of Complement in Multiorgan Failure. Clin Dev Immunol. 2012; 2012: 962–927. DOI: 10.1155/2012/962927.

24. Menges P., Kessler W., Kloecker C., Feuerherd M., Gaubert S., Diedrich S., van der Linde J., A. Hegenbart, Busemann A., Traeger T., Cziupka K., Heidecke C.-D., Maier S. Surgical Trauma and Postoperative Immune Dysfunction. Eur Surg Res 2012; 48: 180–186. DOI: 10.1159/000338196.

25. Grigoryev E.V., Shukevich D.L., Matveeva V.G., Kornekyuk R.A. Immunosuppression as a component of multiple organ dysfunction syndrome followed cardiac surgery. Kompleksnye problemy serdechno-sosudistyh zabolevanij.2018; 7 (4): 84–91. DOI: 10.17802/2306-1278-2018-7-4-84-91.

26. Delano M.J., Ward P.A. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? Clin Invest. 2016; 126 (1): 23–31. DOI: 10.1172/JCI82224.

27. Rankin J.S., Oguntolu O., Binford R.S., Trochtenberg D.S., Muhlbaier L.H., Stratton C.W. Management of immune dysfunction after adult cardiac surgery. J Thorac Cardiovasc Surg. 2011 Sep; 142 (3): 575–580. DOI: 10.1016/j.jtcvs.2011.04.042.

28. Gaudriot B., Uhel F., Gregoire M., Gacouin A., Biedermann S., Roisne A., Flecher E., Le Y.Tulzo, Tarte K., Tadie J.-M. Immune Dysfunction After Cardiac Surgery with Cardiopulmonary Bypass: Beneficial Effects of Maintaining Mechanical Ventilation. Shock. 2015 Sep; 44 (3): 228–233. DOI: 10.1097/SHK.0000000000000416.

29. Bronicli R.A., Hall M. Cardiopulmonary bypass-induced inflammatory response: Pathophysiology and treatment. Pediatric Critical Care Medicine. 2016 Aug; 17 (8 Suppl 1): S272–S278. DOI: 10.1097/PCC.0000000000000759.